Published in Biochemistry on December 22, 2015
Mitochondrial lipids in neurodegeneration. Cell Tissue Res (2016) 0.75
Endoplasmic Reticulum Malfunction in the Nervous System. Front Neurosci (2017) 0.75
Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's disease. Sci Rep (2017) 0.75
Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids (1970) 11.81
Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science (1997) 11.53
Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell (1997) 9.57
CNS synaptogenesis promoted by glia-derived cholesterol. Science (2001) 6.04
Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell (2004) 5.67
Essential role of phosphoinositide metabolism in synaptic vesicle recycling. Cell (1999) 4.70
Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila. Neuron (2003) 4.04
Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. Hum Mol Genet (2000) 3.87
Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles. Nat Cell Biol (2000) 3.55
Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils. Proc Natl Acad Sci U S A (2000) 3.43
Micropatterning fluid lipid bilayers on solid supports. Science (1997) 3.11
Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron (1995) 3.08
Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complex aggregation mechanism. Nat Struct Mol Biol (2009) 2.77
Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity. Hum Mol Genet (2007) 2.51
Lipid composition of the normal human brain: gray matter, white matter, and myelin. J Lipid Res (1965) 2.35
High cholesterol level is essential for myelin membrane growth. Nat Neurosci (2005) 2.34
Identifying polyglutamine protein species in situ that best predict neurodegeneration. Nat Chem Biol (2011) 2.24
N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking. J Neurosci (2008) 2.18
Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease. J Biol Chem (2010) 2.10
SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis. Proc Natl Acad Sci U S A (2010) 2.09
Solubilization and disaggregation of polyglutamine peptides. Protein Sci (2001) 2.00
Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease. Proc Natl Acad Sci U S A (2004) 2.00
Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis. Proc Natl Acad Sci U S A (2001) 1.99
Secondary structure of Huntingtin amino-terminal region. Structure (2009) 1.98
Distinct conformations of in vitro and in vivo amyloids of huntingtin-exon1 show different cytotoxicity. Proc Natl Acad Sci U S A (2009) 1.96
The size of lipid rafts: an atomic force microscopy study of ganglioside GM1 domains in sphingomyelin/DOPC/cholesterol membranes. Biophys J (2002) 1.91
Cholesterol's interfacial interactions with sphingomyelins and phosphatidylcholines: hydrocarbon chain structure determines the magnitude of condensation. Biochemistry (1994) 1.89
Huntingtin as an essential integrator of intracellular vesicular trafficking. Trends Cell Biol (2009) 1.88
Local anesthetics and pressure: a comparison of dibucaine binding to lipid monolayers and bilayers. Biochim Biophys Acta (1987) 1.71
Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease. J Neurosci (2005) 1.68
Regulation of receptor function by cholesterol. Cell Mol Life Sci (2000) 1.67
Huntingtin-HAP40 complex is a novel Rab5 effector that regulates early endosome motility and is up-regulated in Huntington's disease. J Cell Biol (2006) 1.55
Mutant huntingtin N-terminal fragments of specific size mediate aggregation and toxicity in neuronal cells. J Biol Chem (2009) 1.47
Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles. Hum Mol Genet (2000) 1.45
Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses. Hum Mol Genet (2002) 1.45
Origins of phase contrast in the atomic force microscope in liquids. Proc Natl Acad Sci U S A (2009) 1.38
Huntingtin bodies sequester vesicle-associated proteins by a polyproline-dependent interaction. J Neurosci (2004) 1.27
Huntingtin associates with acidic phospholipids at the plasma membrane. J Biol Chem (2005) 1.22
Cholesterol, a modulator of membrane-associated Abeta-fibrillogenesis and neurotoxicity. J Mol Biol (2001) 1.20
Mutant huntingtin inhibits clathrin-independent endocytosis and causes accumulation of cholesterol in vitro and in vivo. Hum Mol Genet (2006) 1.19
Abeta42-peptide assembly on lipid bilayers. J Mol Biol (2002) 1.18
Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease. Brain (2008) 1.16
Cholesterol metabolism in Huntington disease. Nat Rev Neurol (2011) 1.14
Converging pathways in the occurrence of endoplasmic reticulum (ER) stress in Huntington's disease. Curr Mol Med (2011) 1.14
Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation. Hum Mol Genet (2007) 1.13
Lipid rafts and the control of neurotrophic factor signaling in the nervous system: variations on a theme. Curr Opin Neurobiol (2002) 1.12
The relationship between CAG repeat length and clinical progression in Huntington's disease. Mov Disord (2008) 1.12
Emerging roles for cholesterol in Huntington's disease. Trends Neurosci (2011) 1.10
Progressive dysfunction of the cholesterol biosynthesis pathway in the R6/2 mouse model of Huntington's disease. Neurobiol Dis (2007) 1.08
A stress sensitive ER membrane-association domain in Huntingtin protein defines a potential role for Huntingtin in the regulation of autophagy. Autophagy (2007) 1.07
Polyglutamine expansion in huntingtin alters its interaction with phospholipids. J Neurochem (2009) 1.03
Structure and topology of the huntingtin 1-17 membrane anchor by a combined solution and solid-state NMR approach. Biophys J (2013) 1.01
Biophysical insights into how surfaces, including lipid membranes, modulate protein aggregation related to neurodegeneration. Front Neurol (2013) 0.96
The interaction of polyglutamine peptides with lipid membranes is regulated by flanking sequences associated with huntingtin. J Biol Chem (2013) 0.94
Membrane interactions of the amphipathic amino terminus of huntingtin. Biochemistry (2013) 0.93
Whole body cholesterol metabolism is impaired in Huntington's disease. Neurosci Lett (2011) 0.92
Interaction of huntingtin fragments with brain membranes--clues to early dysfunction in Huntington's disease. J Neurochem (2006) 0.92
An organic phosphorus assay which avoids the use of hazardous perchloric acid. Clin Chim Acta (1982) 0.90
Comparative behavior of sterols in phosphatidylcholine-sterol monolayer films. Biochim Biophys Acta (2001) 0.90
Multiple phenotypes in Huntington disease mouse neural stem cells. Mol Cell Neurosci (2012) 0.89
Altered cholesterol homeostasis contributes to enhanced excitotoxicity in Huntington's disease. J Neurochem (2010) 0.89
Assessing mutant huntingtin fragment and polyglutamine aggregation by atomic force microscopy. Methods (2010) 0.88
Amyloid-forming proteins alter the local mechanical properties of lipid membranes. Biochemistry (2013) 0.88
The impairment of cholesterol metabolism in Huntington disease. Biochim Biophys Acta (2015) 0.87
Mechanisms of the Liebermann-Burchard and Zak color reactions for cholesterol. Clin Chem (1974) 0.86
Atomic force microscopy imaging of lipid rafts of human breast cancer cells. Biochim Biophys Acta (2012) 0.85
Huntingtin disrupts lipid bilayers in a polyQ-length dependent manner. Biochim Biophys Acta (2013) 0.84
Polyglutamine expansion in huntingtin increases its insertion into lipid bilayers. Biochem Biophys Res Commun (2009) 0.83
Specific domains of Aβ facilitate aggregation on and association with lipid bilayers. J Mol Biol (2013) 0.81
The effects of flanking sequences in the interaction of polyglutamine peptides with a membrane bilayer. J Phys Chem B (2014) 0.81
Huntingtin interactions with membrane phospholipids: strategic targets for therapeutic intervention? J Huntingtons Dis (2013) 0.81
Pitfalls in the detection of cholesterol in Huntington's disease models. PLoS Curr (2012) 0.80
A multifunctional, multi-pathway intracellular localization signal in Huntingtin. Commun Integr Biol (2013) 0.79
The modulating effect of mechanical changes in lipid bilayers caused by apoE-containing lipoproteins on Aβ induced membrane disruption. ACS Chem Neurosci (2011) 0.78
Probing the Huntingtin 1-17 membrane anchor on a phospholipid bilayer by using all-atom simulations. Biophys J (2015) 0.78
Mapping the mechanical properties of cholesterol-containing supported lipid bilayers with nanoscale spatial resolution. Langmuir (2012) 0.78
Membrane interactions and lipid binding of casein oligomers and early aggregates. Biochim Biophys Acta (2008) 0.77
A quantitative method for the measurement of membrane affinity by polydiacetylene-based colorimetric assay. Anal Biochem (2011) 0.77
Influence of dietary cholesterol on cholesterol metabolism. Ann N Y Acad Sci (1968) 0.76
Point mutations in Aβ induce polymorphic aggregates at liquid/solid interfaces. ACS Chem Neurosci (2011) 0.76